Back to VA VANGUARD CAPITAL MANAGEMENT LLC
CADL2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in CANDEL THERAPEUTICS INC
Yes. Vanguard Capital Management holds 2,694,040 shares of CADL (Candel Therapeutics), worth $27.7M, as of its Q2 2026 13F filing. It increased the position by 231,283 shares (+9.4%) from Q1 2026. Vanguard Capital Management has held CADL in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$27.7M
Current Shares
2.7M
Total Value Change
+$15.7M
Total Shares Change
+231,283
Quarter-by-Quarter History
Other major holders of CADL: FMR LLC, RTW INVESTMENTS, LP, BlackRock, Inc.